Kobayashi Pharmaceutical Co., Ltd. (TSE:4967) announces a share repurchase program. Under the program, the company will repurchase up to 1,000,000 shares, representing 1.28% of its issued share capital for ?8,000 million. The purpose of the program is to return profits to shareholders and implement agile capital policies in response to changes in the business environment. The program is valid till June 23, 2022. As of September 30, 2021, the company had 78,163,016 shares issued (excluding treasury stock) and 3,886,984 shares in treasury.